choreiform movement
Recently Published Documents


TOTAL DOCUMENTS

19
(FIVE YEARS 1)

H-INDEX

7
(FIVE YEARS 0)

2021 ◽  
Vol 429 ◽  
pp. 119822
Author(s):  
Wolfgang Trillo Alvarez ◽  
Joaquin Molina Acosta ◽  
Ximena Flores Callohuanca ◽  
Claudio Ibañez Escalante ◽  
Gabriel Calderón Paiva ◽  
...  

2020 ◽  
Vol 9 (3) ◽  
pp. 283-289 ◽  
Author(s):  
Jaslovleen Kaur ◽  
Shaista Parveen ◽  
Uzma Shamim ◽  
Pooja Sharma ◽  
Varun Suroliya ◽  
...  

Background: The diagnostic workup for choreiform movement disorders including Huntington’s disease (HD) and those mimicking HD like phenotype is complex. Objective: The aim of the present study was to genetically define HD and HD-like presentations in an Indian cohort. We also describe HTT-CAG expansion manifesting as neuroferritinopathy-like disorder in four families from Punjab in India. Materials and methods: 159 patients clinically diagnosed as HD and HD-like presentations from various tertiary neurology clinics were referred to our centre (CSIR-IGIB) for genetic investigations. As a first tier test, CAG-TNR for HTT was performed and subsequently HD-negative samples were screened for JPH3 (HDL2), TBP (SCA17), ATN1 (DRPLA), PPP2R2B (SCA12) and GGGGCC expansion in C9orf72 gene. Four families presenting as neuroferritinopathy-like disorder were also investigated for HTT-CAG expansion. Results: 94 of 159 (59%) patients were found to have expanded HTT-CAG repeats. Pathogenic repeat expansion in JPH3, TBP, ATN1 and C9orf72 were not found in HD negative cases. Two patients were positive for SCA12-CAG expansion in pathogenic length, whereas 5 cases harboured TBP-CAG repeats falling in reduced penetrance range of 41– 48 repeats for SCA17. Four unrelated families, presented with atypical chorea and brain MRI findings suggestive of basal ganglia abnormalities mimicking neuroferritinopathy were found to harbour HTT-CAG expansion. Conclusion: We present SCA12 as a new reported phenocopy of HD which should be considered for diagnostic workout along with SCA17 for HD-like syndromes. This study also illustrates the necessity, to consider evolving HD like phenotype, as a clinical diagnosis for cases with initial manifestations depicting neuroferritinopathy.


2020 ◽  
Vol 10 (1) ◽  
pp. 9-13
Author(s):  
Adrian I Espiritu ◽  
Gerard Raimon M Saranza ◽  
Veeda Michelle M Anlacan ◽  
Cezar Thomas R Suratos ◽  
Roland Dominic G Jamora

Binswanger disease (BD) involves injuries to the brain small vessels, resulting to gradually progressive subcortical ischemia. This disorder manifests with dementia, gait abnormalities, upper motor signs and parkinsonism, and presents as extensive, confluent, bilateral cerebral white matter hyperintensities in the MRI. Cases of BD typically manifests with vascular risk factors, such as hypertension and multiple strokes. We report a unique case of a Filipino patient whom we have diagnosed with BD presenting with no cardinal signs of parkinsonism, but with generalized choreiform movement disorder and without a history of hypertension and symptomatic strokes. To our knowledge, this is the first report presenting an adult patient with subcortical leukoaraiosis of Binswanger type associated with a hyperkinetic movement disorder.


2019 ◽  
Vol 47 (12) ◽  
pp. 6390-6396
Author(s):  
Shu-Ting Li ◽  
Yang Zhou

Spinocerebellar ataxia type 2 (SCA2) is a rare disease characterized by slowly progressive ataxia, dysarthria, ophthalmoplegia, and slow saccade. SCA2 can present with a complex combination of hyperkinetic and hypokinetic movement disorders. Here, we describe a patient with SCA2 that partly mimicked the clinical manifestations of Huntington’s disease; similar symptoms had previously occurred in the patient’s family members. The findings in this report indicate that, when a patient exhibits choreiform movement (i.e., accompanying cerebellar ataxia), an SCA2-related mutation could be responsible for the onset of disease. In addition, this knowledge of the potential for extrapyramidal involvement in such patients is critical for clinicians.


2019 ◽  
Vol 6 (3) ◽  
pp. e557 ◽  
Author(s):  
Nathalie Lamby ◽  
Frank Leypoldt ◽  
Jörg B. Schulz ◽  
Simone C. Tauber

2018 ◽  
Vol 48 (3) ◽  
pp. 138
Author(s):  
Gisele N.M. Sion ◽  
Aline C. Moraes ◽  
Barbara M.R. Sousa ◽  
Pedro M.G. Molina ◽  
Eduardo A.R. Silva ◽  
...  
Keyword(s):  

2018 ◽  
Vol 22 (3) ◽  
pp. 516-524 ◽  
Author(s):  
Naama Orenstein ◽  
Hadassa Goldberg-Stern ◽  
Rachel Straussberg ◽  
Lily Bazak ◽  
Monika Weisz Hubshman ◽  
...  

2017 ◽  
Vol 39 (3) ◽  
pp. 140-142
Author(s):  
Ali Sonmez ◽  
Mehmet Fatih Gol ◽  
Fusun Ferda Erdogan

2000 ◽  
Vol 92 (4) ◽  
pp. 718-721 ◽  
Author(s):  
Todd P. Thompson ◽  
Douglas Kondziolka ◽  
A. Leland Albright

✓ Surgery for movement disorders is most commonly performed in patients with dyskinesia and tremor associated with Parkinson's disease or in those with essential tremor. The role of ablative surgery or deep brain stimulation in patients with choreiform movements is poorly defined.The authors placed thalamic stimulation systems in two children with disabling choreiform disorders due to intracerebral hemorrhage or cerebral palsy. Each patient displayed choreiform movements in the upper extremities both at rest and with intention, which interfered with daily activities and socialization. Both children obtained significant improvement in their choreiform movements, and their upper extremity function improved with no incidence of morbidity. Thalamic stimulation appears to be a promising and nonablative approach for children with choreiform movement disorders.


Sign in / Sign up

Export Citation Format

Share Document